Howard Monsour

Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study

David Roth, David R. Nelson, Annette Bruchfeld et al. · The Lancet · 2015 · 663 citations · Full text

Hepatic Disorders, Hepatitis C, Viral Hepatitis +10

Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1

Thomas Boyer, Arun J. Sanyal, Florence Wong et al. · Gastroenterology · 2016 · 302 citations · Full text

Hepatology, Liver Physiology, Pharmacology +7

Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series

Keri E. Lunsford, Milind Javle, Kirk Heyne et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 283 citations

Surgical Oncology, Hepatology, Neoadjuvant Therapy +10

The role of choledochoscopy in the diagnosis and management of biliary tract diseases

Iqbal Siddique, Joseph Galati, Victor Ankoma‐Sey et al. · Gastrointestinal Endoscopy · 1999 · 113 citations

Biliary Tract Diseases, Eus-guided Gallbladder Drainage, Hepatology +10

Elbasvir plus grazoprevir in patients with hepatitis C virus infection and stage 4–5 chronic kidney disease: clinical, virological, and health-related quality-of-life outcomes from a phase 3, multicentre, randomised, double-blind, placebo-controlled trial

Annette Bruchfeld, David Roth, Paul Martin et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 76 citations

Hepatic Disorders, Hepatology, Hepatitis C +8